Introduction
Lichen sclerosus is a chronic, inflammatory skin condition that primarily affects the vulva. It causes white, patchy skin changes, itching, burning, soreness, and — over time without treatment — progressive architectural changes including scarring, fusion of the labia, and narrowing of the vaginal introitus. For women in Houston, Sugar Land, Missouri City, Stafford, and Richmond dealing with this condition, treatment options have traditionally been limited to high-potency topical corticosteroids. PRP has emerged as a promising complementary or alternative option, though with important nuances worth understanding.
What Lichen Sclerosus Is and How It Affects Women
Lichen sclerosus (LS) has an estimated prevalence of roughly 1 in 70-100 women, though it is likely underdiagnosed. It can affect women of any age but is most common in postmenopausal women. The condition involves chronic inflammation that damages the dermal architecture of vulvar tissue — thinning the epidermis, disrupting collagen organization, and causing progressive sclerosis (hardening) of the underlying dermis.
Symptoms include intense vulvar itching (often worse at night), burning and soreness, pain during intercourse, and changes in the appearance of vulvar tissue — including whitening, fragility, and over time, structural changes that can affect sexual function and urination.
The standard treatment — high-potency topical corticosteroids (typically clobetasol propionate) — is effective for controlling symptoms and slowing progression, but does not reverse established scarring and requires lifelong use.
How PRP May Help in Lichen Sclerosus
PRP’s potential role in lichen sclerosus treatment is based on its collagen-stimulating and tissue-regenerating properties. The growth factors delivered by PRP — particularly TGF-β and PDGF — promote collagen type III synthesis (more flexible, less scarred tissue) and tissue remodeling. Anti-inflammatory effects have also been attributed to PRP, which may address the chronic inflammation that drives disease progression.
A case report published in a peer-reviewed journal described the use of PRP combined with lipofilling in a 67-year-old patient with vaginal atrophy and lichen sclerosus. The treatment produced significant symptom improvement and remission of the lichen sclerosus lesions on the labia minora, with the researchers concluding that ‘lipofilling with PRP can be effective for vaginal atrophy and lichen sclerosus.’
Important Caveats
The evidence for PRP in lichen sclerosus is currently limited to case reports and small series. This is a meaningful distinction from conditions like vaginal atrophy or stress urinary incontinence, where PRP has been studied in larger cohort studies. Lichen sclerosus is a complex immune-mediated condition, and PRP is not a substitute for established treatments — particularly when the disease is active.
Women with lichen sclerosus who are interested in PRP should have a frank conversation with both their dermatologist or gynecologist managing the LS and a PRP provider. A coordinated approach — continuing appropriate standard treatment while considering PRP as a complement — is the most sensible strategy.
Additionally, lichen sclerosus carries a small but real risk of vulvar malignancy, and any new or changing lesions must be properly evaluated before pursuing aesthetic or regenerative treatments.
What the Consultation Should Include
For Houston area women with lichen sclerosus considering PRP, the consultation should include: confirmation of your LS diagnosis and current treatment status; a discussion of the limited but encouraging evidence for PRP in this specific condition; realistic expectations about what PRP can and cannot achieve; coordination with your LS-managing physician; and a clear plan for monitoring.
Conclusion
PRP vaginal rejuvenation shows early promise as a complementary treatment for lichen sclerosus, building on its established role in treating vaginal atrophy and tissue regeneration. For Houston area women with LS who are looking for additional options beyond topical corticosteroids, PRP is worth exploring — with appropriate medical supervision and realistic expectations.